RetinaPharma is a privately-held biotechnology company developing advanced technologies for blinding retinal diseases such as glaucoma, macular degeneration, an...
| Website | http://www.retinapharma.com |
| Revenue | $5.8 million |
| Employees | View employees |
| Address | 324 S Hyde Park Ave, Tampa, Florida 33606, US |
| Phone | +1 215-885-4558 |
| Industry | Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Health Care, Life Science, Medical |
| Competitors | Roche, Novartis, AbbVie, Genentech, Amgen, Regeneron, Alcon, Bausch + Lomb, JnJ Vision Surgical EMEA, EyeGate Pharma (Nasdaq:EYEG) +33 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Retinapharma Technologies employee's phone or email?
Retinapharma Technologies Questions
The Retinapharma Technologies annual revenue was $5.8 million in 2026.
Retinapharma Technologies is based in Tampa, Florida.
The NAICS codes for Retinapharma Technologies are [325, 3254, 32, 32541].
The SIC codes for Retinapharma Technologies are [28, 2834, 283].
G2Crowd Trusted
300K+
Plugin Users
